Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050136

Director sold 9,437 shares at an average $9.30 ($87,778)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HOLLER FRANK A Director 2019-09-17 Sale −5,069 $9.32 $47,243 136,129 D
HOLLER FRANK A Director 2019-09-18 Sale −4,368 $9.28 $40,535 131,761 D
Derivatives
HOLLER FRANK A Director 2019-09-16 Grant or award · Stock Option (Right to Buy) +15,000 15,000 D
Open-market sales · 9,437 sh · avg $9.30 · $87,778
Loading xslF345X03/doc4.xml…